David E. I. Pyott, Director at Edwards Lifesciences Corp (EW), sold 20,000 shares at $76.95 ($1.5M) on 2012-01-18, disclosed to the SEC on 2012-01-18.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALNY | SELL | 2024-06-26 | $7.2M | — | Filing → |
| BMRN | BUY | 2020-09-01 | $1.0M | — | Filing → |
| AVY | SELL | 2020-02-05 | $1.3M | — | Filing → |